Trexquant Investment LP Madrigal Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$203.88 - $312.0 $203,880 - $312,000	1,000 Added 18.32%	6,460 $1.49 Million
Q1 2023 May 15, 2023	SELL	$231.06 - $307.08 $1.32 Million - $1.76 Million	-5,730 Reduced 51.21%	5,460 $1.32 Million
Q4 2022 Feb 13, 2023	BUY	$58.39 - $296.54 $653,384 - $3.32 Million	11,190 New	11,190 $3.25 Million
Q3 2021 Nov 12, 2021	SELL	$78.35 - $105.02 $162,968 - $218,441	-2,080 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$97.2 - $137.59 $202,176 - $286,187	2,080 New	2,080 $203,000
Q4 2020 Feb 11, 2021	SELL	$110.06 - $133.7 $269,867 - $327,832	-2,452 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$99.78 - $124.21 $187,486 - $233,390	-1,879 Reduced 43.38%	2,452 $291,000
Q2 2020 Aug 07, 2020	SELL	$60.13 - $125.71 $42,211 - $88,248	-702 Reduced 13.95%	4,331 $490,000
Q1 2020 May 08, 2020	BUY	$66.76 - $93.49 $336,003 - $470,535	5,033 New	5,033 $336,000

336

22.3M

960K

940K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.84B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.